Article
Value of multi-center 18F-FDG PET/CT radiomics in predicting EGFR mutation status in lung adenocarcinoma.
Medical physics - 1 Jul 2024
Zuo Yan, Liu Liu, Chang Cheng, Yan Hui, Wang Lihua, Sun Dazhen, Ruan Maomei, Lei Bei, Xia Xunpeng, Xie Wenhui, Song Shaoli, Huang Gang
Abstract excerpt
BACKGROUND: Accurate, noninvasive, and reliable assessment of epidermal growth factor receptor (EGFR) mutation status and EGFR molecular subtypes is essential for treatment plan selection and individualized therapy in lung adenocarcinoma (LUAD). Radiomics models based on 18F-FDG PET/CT have great potential in identifying EGFR mutation status and EGFR subtypes in patients with LUAD. The validation of multi-center...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
